Why PMV Pharmaceuticals, Inc. (PMVP) Faces Funding Concerns Despite Positive Trial Activity
TheFly reported on May 13 that Oppenheimer reduced its price target on PMVP from $6 to $5 while maintaining an Outperform rating after the company’s latest qu...